Baxter International Inc logo

Baxter International Inc

NEW
NYSE:BAX (USA)   Ordinary Shares
$ 22.21 +0.14 (+0.63%) 04:00 PM EST
At Loss
P/B:
1.90
Market Cap:
$ 11.47B
Enterprise V:
$ 19.11B
Volume:
3.96M
Avg Vol (2M):
6.61M
Trade In:
Volume:
3.96M
At Loss
Avg Vol (2M):
6.61M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Baxter International Inc ( ) from 1990 to Jul 21 2026. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Baxter International stock (BAX) PE ratio as of Jul 21 2026 is 0. More Details

Baxter International Inc (BAX) PE Ratio (TTM) Chart

To

Baxter International Inc (BAX) PE Ratio (TTM) Historical Data

Total 1207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Baxter International PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2026-07-21 At Loss 0 0 0 2026-05-14 At Loss 0 0 0
2026-07-20 At Loss 0 0 0 2026-05-13 At Loss 0 0 0
2026-07-17 At Loss 0 0 0 2026-05-12 At Loss 0 0 0
2026-07-16 At Loss 0 0 0 2026-05-11 At Loss 0 0 0
2026-07-15 At Loss 0 0 0 2026-05-08 At Loss 0 0 0
2026-07-14 At Loss 0 0 0 2026-05-07 At Loss 0 0 0
2026-07-13 At Loss 0 0 0 2026-05-06 At Loss 0 0 0
2026-07-10 At Loss 0 0 0 2026-05-05 At Loss 0 0 0
2026-07-09 At Loss 0 0 0 2026-05-04 At Loss 0 0 0
2026-07-08 At Loss 0 0 0 2026-05-01 At Loss 0 0 0
2026-07-07 At Loss 0 0 0 2026-04-30 At Loss 0 0 0
2026-07-06 At Loss 0 0 0 2026-04-29 At Loss 0 0 0
2026-07-02 At Loss 0 0 0 2026-04-28 At Loss 0 0 0
2026-07-01 At Loss 0 0 0 2026-04-27 At Loss 0 0 0
2026-06-30 At Loss 0 0 0 2026-04-24 At Loss 0 0 0
2026-06-29 At Loss 0 0 0 2026-04-23 At Loss 0 0 0
2026-06-26 At Loss 0 0 0 2026-04-22 At Loss 0 0 0
2026-06-25 At Loss 0 0 0 2026-04-21 At Loss 0 0 0
2026-06-24 At Loss 0 0 0 2026-04-20 At Loss 0 0 0
2026-06-23 At Loss 0 0 0 2026-04-17 At Loss 0 0 0
2026-06-22 At Loss 0 0 0 2026-04-16 At Loss 0 0 0
2026-06-18 At Loss 0 0 0 2026-04-15 At Loss 0 0 0
2026-06-17 At Loss 0 0 0 2026-04-14 At Loss 0 0 0
2026-06-16 At Loss 0 0 0 2026-04-13 At Loss 0 0 0
2026-06-15 At Loss 0 0 0 2026-04-10 At Loss 0 0 0
2026-06-12 At Loss 0 0 0 2026-04-09 At Loss 0 0 0
2026-06-11 At Loss 0 0 0 2026-04-08 At Loss 0 0 0
2026-06-10 At Loss 0 0 0 2026-04-07 At Loss 0 0 0
2026-06-09 At Loss 0 0 0 2026-04-06 At Loss 0 0 0
2026-06-08 At Loss 0 0 0 2026-04-02 At Loss 0 0 0
2026-06-05 At Loss 0 0 0 2026-04-01 At Loss 0 0 0
2026-06-04 At Loss 0 0 0 2026-03-31 At Loss 0 0 0
2026-06-03 At Loss 0 0 0 2026-03-30 At Loss 0 0 0
2026-06-02 At Loss 0 0 0 2026-03-27 At Loss 0 0 0
2026-06-01 At Loss 0 0 0 2026-03-26 At Loss 0 0 0
2026-05-29 At Loss 0 0 0 2026-03-25 At Loss 0 0 0
2026-05-28 At Loss 0 0 0 2026-03-24 At Loss 0 0 0
2026-05-27 At Loss 0 0 0 2026-03-23 At Loss 0 0 0
2026-05-26 At Loss 0 0 0 2026-03-20 At Loss 0 0 0
2026-05-22 At Loss 0 0 0 2026-03-19 At Loss 0 0 0
2026-05-21 At Loss 0 0 0 2026-03-18 At Loss 0 0 0
2026-05-20 At Loss 0 0 0 2026-03-17 At Loss 0 0 0
2026-05-19 At Loss 0 0 0 2026-03-16 At Loss 0 0 0
2026-05-18 At Loss 0 0 0 2026-03-13 At Loss 0 0 0
2026-05-15 At Loss 0 0 0 2026-03-12 At Loss 0 0 0

Baxter International Inc (BAX) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Baxter International Inc logo
Baxter International Inc
NAICS : 339112 SIC : 3841
ISIN : US0718131099

Share Class Description:

BAX: Ordinary Shares

Total Employee Number:

37,500
Description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.